Corporate Law & Corporate Finance

The healthcare market has been one of the economy’s fastest growing sectors, not only since the COVID-19 pandemic.

The healthcare market has been one of the economy’s fastest growing sectors, not only since the COVID-19 pandemic. This also applies to corporate finance and M&A transactions. The number of investments in digital health and AI-related applications is growing particularly strongly (Corporate Finance, 2020). Similarly, venture capital and private equity transactions in biopharmaceuticals and health tech are on the rise, both in terms of the number and size of deals. (Deloitte, 2020).

Corporate Law (Corporate/M&A)

Im Bereich Gesellschaftsrecht (Corporate/M&A) beraten wir deutsche und internationale Konzerne, Mittelständler, Finanzinvestoren, Wertpapier-Emittenten, Investmentplattformen sowie schnell wachsende junge Unternehmen in folgenden Bereichen:

  • Unternehmensfinanzierung
  • M&A
  • Venture Capital/Private Equity
  • Kapitalmarktrecht einschließlich digitale Investments

Venture Capital 

In the area of venture capital as well as capital markets law:

  • Prospectus law (EU Securities Prospectus Regulation)
  • German Capital Investment Act
  • Law governing financial investment brokerage and investment advice (Section 1 German Banking Act, Financial Investment Brokerage Ordinance)
  • Crowdfunding (e.g., proposal for the adoption of an EU Regulation for European Crowdfunding Service Providers (ECSP)).

In addition, we have been providing pro bono support for numerous start-up topics for years and are acting as lecturers for various university and government-funded incubators and accelerators.

Our 5 experts for Corporate Law & Corporate Finance

Marion  Anzinger

Marion Anzinger

Partner

Dr. Martin  Böttger

Dr. Martin Böttger

Partner

Dr. Matthias  Nordmann

Dr. Matthias Nordmann

Partner

Dr. Kolja  Petrovicki

Dr. Kolja Petrovicki

Partner

Dr. Tatjana  Schroeder

Dr. Tatjana Schroeder

Partner